Skip to main content

Publications

featured publications

  • A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.

    Blood

    Authors: Guy Young, Ri Liesner, Tiffany Chang, Robert Sidonio, Johannes Oldenburg, Victor Jiménez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Marianne Uguen, Michelle Y Doral, Lilyan Y Wright, Christophe Schmitt, Gallia G Levy, Midori Shima, Maria Elisa Mancuso

  • Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs.

    Transfusion

    Authors: Katarzyna I Jankowska, Joseph McGill, Behnaz Pezeshkpoor, Johannes Oldenburg, Chintamani D Atreya, Zuben E Sauna

  • Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.

    Blood

    Authors: Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Pratima Chowdary, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Young, Silva Zupancic-Salek, Johannes Oldenburg

  • The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

    Biomolecules

    Authors: Sneha Singh, Alexis Nazabal, Senthilvelrajan Kaniyappan, Jean-Luc Pellequer, Alisa S Wolberg, Diana Imhof, Johannes Oldenburg, Arijit Biswas

  • Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Shariq Ahmed, Hamideh Yadegari, Arshi Naz, Arijit Biswas, Ulrich Budde, Nazish Saqlain, Samina Amanat, Shehla Tariq, Fazle Raziq, Shahtaj Masood, Anna Pavlova, Tahir Sultan Shamsi, Johannes Oldenburg

  • Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy.

    Current medical research and opinion

    Authors: Johannes Oldenburg, Songkai Yan, Geraldine Maro, Girishanthy Krishnarajah, Andreas Tiede

  • Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.

    VASA. Zeitschrift fur Gefasskrankheiten

    Authors: Rupert Bauersachs, Florian Langer, Christoph Kalka, Stavros Konstantinides, Robert Klamroth, Johannes Oldenburg, Sebastian Schellong, Ute Scholz, Markus Stücker, Edelgard Lindhoff-Last

  • Structure functional insights into calcium binding during the activation of coagulation factor XIII A.

    Scientific reports

    Authors: Sneha Singh, Johannes Dodt, Peter Volkers, Emma Hethershaw, Helen Philippou, Vytautus Ivaskevicius, Diana Imhof, Johannes Oldenburg, Arijit Biswas

  • Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.

    Circulation research

    Authors: Heiko Rühl, Christina Berens, Franziska I Winterhagen, Sara Reda, Jens Müller, Johannes Oldenburg, Bernd Pötzsch

  • Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains.

    Journal of thrombosis and thrombolysis

    Authors: Mohammad Suhail Akhter, Sneha Singh, Hamideh Yadegari, Vytautas Ivaskevicius, Johannes Oldenburg, Arijit Biswas